Research on the sharing mechanism of drug price information in China- from the perspective of intergovernmental information sharing

doi:10.5246/jcps.2018.08.059

Journal of Chinese Pharmaceutical Sciences ›› 2018, Vol. 27 ›› Issue (8): 582-587.DOI: 10.5246/jcps.2018.08.059

• Drug administration and clinical pharmacy column • Previous Articles Next Articles

Research on the sharing mechanism of drug price information in China- from the perspective of intergovernmental information sharing

Shuai Wang¹, Ting Yin¹, Ningtai Luo¹, Xiaoping Liu², Bin Jiang^1*

1. Department of Administrative and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
2. China Society for Drug Regulation, Beijing 100050, China

Received:2018-05-28 Revised:2018-06-29 Online:2018-09-04 Published:2018-07-13
Contact: Tel.: +86-13601100121, E-mail: binjiang@bjmu.edu.cn
Supported by:
China Society for Drug Regulation (Grant No. 20170518).

Abstract

Abstract:

Establishment of sharing mechanism for drug price information to guarantee the construction of a unified cross-departmental price information platform is a new national policy after Chinese government abandoned drug price control. Based on the theory of intergovernmental information sharing, this study aimed to investigate the drug price information sharing mechanism in China through literature research and stakeholder interviews, which included institution guarantee mechanism, department coordination mechanism and technical support mechanism.

Key words: Drug price, Information sharing mechanism, Cross-departmental price information platform, Intergovernmental information sharing

CLC Number:

R951

Supporting:

Shuai Wang, Ting Yin, Ningtai Luo, Xiaoping Liu, Bin Jiang. Research on the sharing mechanism of drug price information in China- from the perspective of intergovernmental information sharing[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(8): 582-587.

References

[1] Chen, C.; Li, B.; Yang, D.S.; Jiang, B. Implementation of NFS (2012) in Qingdao: from the perspective of public policy implementation. Chin. Pharm. Sci. 2016, 25, 779−784.

[2] Yu, J.X.; Que, M.Y.; Wang, S.; Yin, T.; Wang, J.; Yang, S.; Jiang, B. Framework and local experience of pharmaceutical reimbursement criteria policy (PRCP) in China. Chin. Pharm. Sci. 2017, 26, 390–394

[3] Chen, L.J.; liu, G.Z.; Huang, G.; Yang, D.h.; Jiang, B. Institutional changes of China’s drug regulation and improvement solutions. Chin. Pharm. Sci. 2015, 24, 821–825

[4] Dawes, S.S. Interagency information sharing: Expected benefits, manageable risks. J. Policy. Anal. Manage. 1996, 15, 377−394.

[5] Landsbergen, D.J.; Wolken, G.J. Realizing the promise: Government information systems and the fourth generation of information technology. Public. Adm. Rev. 2001, 61, 206−220.

[6] Yang, T.M. Information-sharing in public organizations: A literature review of interpersonal, intra-organizational and inter-organizational success factors. Gov. Inform. Q. 2001, 28, 164–175.

[7] Ramon Gil-Garcia, J.; Djoko, S.S. Government inter-organizational information sharing initiatives:understanding the main determinants of success. Gov. Inform. Q. 2016, 33, 572–582

[8] Bekkers, V. Flexible information infrastructures in Dutch E-government collaboration arrangements: Experiences and policy implications. Gov. Inform. Q. 2009, 26, 60–68.

[9] Yang, T.M.; Wu, Y.J. What to share and why to share? A case study of cross-boundary information sharing in Taiwan e-government. J. Libr. Inform. Stud. 2013, 11, 25–53.

[10] Akbulut, A.Y.; Kelle, P.; Pawlowski, S.D.; Schneider, H.; Looney, C.A. To share or not to share? Examining the factors influencing local agency electronic information sharing. Int. J. Bus. Inform. Syst. 2009, 4, 143−172.

[11] Li, S.; Lin, B. Accessing information sharing and information quality in supply chain management. Decis. Support. Syst. 2006, 42, 1641−1656.

[12] Pardo, T.A.; Tayi, G.K. Interorganizational information integration: A key enabler for digital government. Gov. Inform. Q. 2007, 24, 691−715.

[13] Otjacques, B.; Hitzelberger, P.; Feltz, F. Interoperability of e-Government information systems: Issues of identification and data sharing. J. Manage. Inform. Syst. 2007, 23, 29−51.

[1]	Chengxin Xie, Wei Wang, Ge Huang, Xin Jin, Chenglong Wang, Dong Yin. Pharmacist-led interventions to reduce inappropriate drug use in the orthopaedics department in China [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(6): 375-382.
[2]	Yuyao Nie, He Wang, Linguang Zhou, Luwen Shi, Bin Jiang. Pharmacists’ perceptions of generic drugs in China [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(5): 364-368.
[3]	Zhifeng Nie, Chunxia Man, Xin Yi, Yi Liu, Zhigang Guo, Xiaodong Guan, Luwen Shi. Impact of the zero-markup drug policy on volume of medical service: based on 57 county hospitals of China [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(3): 220-226.
[4]	Ruojing Zhou, Bin Jiang. Effects of drug purchasing under joint price caps policy in Fujian Province, China [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(2): 139-152.
[5]	Dongsheng Yang, Lingyun Ma, Jianzhao Niu, Mingdi Xu. Brief introduction for application of USA authorized generic drugs [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(6): 439-445.
[6]	Dongsheng Yang, Lingyun Ma, Jianzhao Niu, Mingdi Xu. Brief introduction for application of the USA national drug code [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(3): 203-208.
[7]	Ting Yin, Bin Jiang. Effects of drug procurement under cap price policy in Sanming [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(11): 799-804.
[8]	Jianzhao Niu, Dongsheng Yang, Mingdi Xu. Brief introduction for search and determination of the comparator product for generic medicinal product application in the EU [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(11): 805-812.
[9]	Shuyun Feng, Jinhui Guo, Yizhong Lu. Pharmaceutical practice and value of pharmacists under the new medical reform situation [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(9): 630-636.
[10]	Mengyuan Que, Ting Yin, Xiaoping Li, Bin Jiang. Status quo of resource allocation of Chinese grass-roots food and drug administrations: from 2011 to 2016 [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(9): 637-643.
[11]	Xiao Chen, Xiang Gao, Jie Chen, Sheryl L Chow, Moses S.S. Chow. New direction for clinical pharmacy in China: adopting a “form follows function” approach to improve future healthcare outcomes [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(5): 352-360.
[12]	Mengyuan Fu, Xiaodong Guan, Guoxu Wei, Xiaoxiong Xin, Luwen Shi. Medical service utilisation, economic burden and health status of patients with rare diseases in China [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(5): 361-369.
[13]	Xianghong Lin, Hao Hu, Yi Liu, Xiaodong Guan, Jiafang Song, Luwen Shi. The comprehensive influence of firm-level factors on drug product internationalization of Chinese pharmaceutical firms [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(3): 209-214.
[14]	Zhiyan Liu, Xiaoyan Nie, Qian Xiang, Luwen Shi, Yimin Cui. Investigations and feedback on the training mode of professional master’s degree of clinical pharmacy in Peking University and the preliminary exploration of Pharm. D. Education [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(2): 131-137.
[15]	Jing Zhang, Xiaoyu Fan, Hongtao Jin, Xingchao Geng. A general introduction to the development of Good Laboratory Practice in China [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(7): 534-544.

Research on the sharing mechanism of drug price information in China- from the perspective of intergovernmental information sharing

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments